Sally R. Wilkes
How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?
Wilkes, Sally R.; Nankervis, Helen; Tavernier, Elsa; Maruani, Annabel; Williams, Hywel C.
Authors
Helen Nankervis
Elsa Tavernier
Annabel Maruani
Professor HYWEL WILLIAMS HYWEL.WILLIAMS@NOTTINGHAM.AC.UK
PROFESSOR OF DERMATO-EPIDEMIOLOGY
Abstract
We sought to explore the architecture of trials of calcineurin inhibitors for atopic eczema to document the extent to which comparisons with active treatments such as topical corticosteroids (TCS) might have been included or avoided. We identified all eligible randomized controlled trials (RCTs) using the Global Resource for EczemA Trials database. Network plots were produced where the nodes represented a treatment type and the lines between the nodes represented the number of trials or participants that were involved in the various treatment comparisons. A total of 174 RCTs for atopic eczema treatments were identified where pimecrolimus, tacrolimus or topical corticosteroids were compared with another intervention or a vehicle/emollient. Of 39 trials involving pimecrolimus and of 41 trials involving tacrolimus, 8 (20.5%) and 13 (31.7%) respectively made comparisons with topical corticosteroids, and 25 (64.1%) and 15 (36.6%) respectively were vehicle-controlled studies. The high rate of comparisons with vehicle controls in RCTs assessing the efficacy of pimecrolimus or tacrolimus long after efficacy had been established is a matter of concern. Active comparators (mild TCS for pimecrolimus and moderate to potent TCS for tacrolimus) are best placed to inform how topical calcineurin inhibitors compare to established clinical practice.
Citation
Wilkes, S. R., Nankervis, H., Tavernier, E., Maruani, A., & Williams, H. C. (2016). How Clinically Relevant Are Treatment Comparisons of Topical Calcineurin Inhibitor Trials for Atopic Eczema?. Journal of Investigative Dermatology, 136(10), 1944-1949. https://doi.org/10.1016/j.jid.2016.05.104
Journal Article Type | Article |
---|---|
Acceptance Date | May 23, 2016 |
Online Publication Date | Jul 20, 2016 |
Publication Date | 2016-10 |
Deposit Date | Jul 10, 2016 |
Publicly Available Date | Jul 20, 2016 |
Journal | Journal of Investigative Dermatology |
Print ISSN | 0022-202X |
Electronic ISSN | 1523-1747 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 136 |
Issue | 10 |
Pages | 1944-1949 |
DOI | https://doi.org/10.1016/j.jid.2016.05.104 |
Keywords | Atopic eczema; Topical corticosteroids; Calcineurin inhibitors; Randomised clinical trial; Network geometry |
Public URL | https://nottingham-repository.worktribe.com/output/800287 |
Publisher URL | http://www.sciencedirect.com/science/article/pii/S0022202X16313331 |
Contract Date | Jul 10, 2016 |
Files
How clinically relevant are treatment comparisons of topical calcineurin inhibitor trials for atopic eczema.pdf
(811 Kb)
PDF
Copyright Statement
Copyright information regarding this work can be found at the following address: http://creativecommons.org/licenses/by-nc-nd/4.0
You might also like
Topical anti-inflammatory treatments for eczema: network meta-analysis
(2024)
Journal Article
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search